{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:13:41Z","timestamp":1794896021403,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04269-7","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:18:54Z","timestamp":1753741134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Global, regional, and national burden and trends of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis in adolescents and adults aged 15\u201349 years from 2010 to 2021: insights from the global burden of disease study 2021"],"prefix":"10.1186","volume":"23","author":[{"given":"Kunping","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"4269_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","volume":"22","author":"M Farhat","year":"2024","unstructured":"Farhat M, Cox H, Ghanem M, Denkinger CM, Rodrigues C, et al. Drug-resistant tuberculosis: a persistent global health concern. Nat Rev Microbiol. 2024;22:617\u201335. https:\/\/doi.org\/10.1038\/s41579-024-01025-1.","journal-title":"Nat Rev Microbiol."},{"key":"4269_CR2","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4:e20. https:\/\/doi.org\/10.1016\/S2666-5247(22)00359-7.","journal-title":"Lancet Microbe."},{"key":"4269_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40249-024-01227-y","volume":"13","author":"SX Zhang","year":"2024","unstructured":"Zhang SX, Miao FY, Yang J, Zhou WT, Lv S, et al. Global, regional, and national burden of HIV-negative tuberculosis, 1990\u20132021: findings from the Global Burden of Disease Study 2021. Infect Dis Poverty. 2024;13:60. https:\/\/doi.org\/10.1186\/s40249-024-01227-y.","journal-title":"Infect Dis Poverty."},{"key":"4269_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","volume":"392","author":"N Ahmad","year":"2018","unstructured":"Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018;392:821\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(18)31644-1.","journal-title":"Lancet."},{"key":"4269_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jinf.2023.06.014","volume":"87","author":"OS Pedersen","year":"2023","unstructured":"Pedersen OS, Holmgaard FB, Mikkelsen MKD, Lange C, Sotgiu G, et al. Global treatment outcomes of extensively drug-resistant tuberculosis in adults: a systematic review and meta-analysis. J Infect. 2023;87:177\u201389. https:\/\/doi.org\/10.1016\/j.jinf.2023.06.014.","journal-title":"J Infect."},{"key":"4269_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/resp.13143","volume":"23","author":"K Dheda","year":"2018","unstructured":"Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, et al. Recent controversies about MDR and XDR-TB: global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology. 2018;23:36\u201345. https:\/\/doi.org\/10.1111\/resp.13143.","journal-title":"Respirology."},{"key":"4269_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1473-3099(19)30568-7","volume":"20","author":"A Dadu","year":"2020","unstructured":"Dadu A, Hovhannesyan A, Ahmedov S, van der Werf MJ, Dara M. Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data. Lancet Infect Dis. 2020;20:250\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(19)30568-7.","journal-title":"Lancet Infect Dis."},{"key":"4269_CR8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12889-021-10267-0","volume":"21","author":"LL Cannon","year":"2021","unstructured":"Cannon LL, Oladimeji KE, Goon DT. Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review. BMC Public Health. 2021;21:488. https:\/\/doi.org\/10.1186\/s12889-021-10267-0.","journal-title":"BMC Public Health."},{"key":"4269_CR9","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1186\/s12889-024-20664-w","volume":"24","author":"H Yang","year":"2024","unstructured":"Yang H, Ruan X, Li W, Xiong J, Zheng Y. Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990\u20132021: a systematic analysis for the Global Burden of Diseases 2021 study. BMC Public Health. 2024;24:3111. https:\/\/doi.org\/10.1186\/s12889-024-20664-w.","journal-title":"BMC Public Health."},{"key":"4269_CR10","doi-asserted-by":"publisher","unstructured":"GBD 2021 Fertility and Forecasting Collaborators. Global fertility in 204 countries and territories, 1950\u20132021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2057\u20132099.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(24)00550-6.","DOI":"10.1016\/S0140-6736(24)00550-6"},{"key":"4269_CR11","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1097\/JS9.0000000000001054","volume":"110","author":"Z Li","year":"2024","unstructured":"Li Z, Zhang X, Sun C, Li Z, Fei H, Zhao D. Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15\u201349 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study. Int J Surg. 2024;110:1929\u201340. https:\/\/doi.org\/10.1097\/JS9.0000000000001054.","journal-title":"Int J Surg."},{"key":"4269_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12890-025-03630-z","volume":"25","author":"Y Li","year":"2025","unstructured":"Li Y, Yan F, Jiang L, Zhen W, Li X, et al. Epidemiological trends and risk factors of chronic obstructive pulmonary disease in young individuals based on the 2021 global burden of disease data (1990\u20132021). BMC Pulm Med. 2025;25:174. https:\/\/doi.org\/10.1186\/s12890-025-03630-z.","journal-title":"BMC Pulm Med."},{"key":"4269_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12957-025-03849-4","volume":"23","author":"X Su","year":"2025","unstructured":"Su X, Chen F, Shi Z, Tao Y, Han X, et al. Global insight of early-onset genitourinary cancers in adolescents and adults from 1990 to 2021: temporal trends and health inequalities analyses. World J Surg Oncol. 2025;23:208. https:\/\/doi.org\/10.1186\/s12957-025-03849-4.","journal-title":"World J Surg Oncol."},{"key":"4269_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/humrep\/deae292","volume":"40","author":"Y Liang","year":"2025","unstructured":"Liang Y, Huang J, Zhao Q, Mo H, Su Z, et al. Global, regional, and national prevalence and trends of infertility among individuals of reproductive age (15\u201349 years) from 1990 to 2021, with projections to 2040. Hum Reprod. 2025;40:529\u201344. https:\/\/doi.org\/10.1093\/humrep\/deae292.","journal-title":"Hum Reprod."},{"key":"4269_CR15","doi-asserted-by":"publisher","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2100\u20132132.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(24)00367-2.","DOI":"10.1016\/S0140-6736(24)00367-2"},{"key":"4269_CR16","doi-asserted-by":"publisher","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133\u20132161. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","DOI":"10.1016\/S0140-6736(24)00757-8"},{"key":"4269_CR17","unstructured":"World Health Organization. Global tuberculosis report 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240083851. Accessed 20 September 2024."},{"key":"4269_CR18","doi-asserted-by":"publisher","unstructured":"GBD 2021 Tuberculosis Collaborators. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024;24:698\u2013725.https:\/\/doi.org\/10.1016\/S1473-3099(24)00007-0.","DOI":"10.1016\/S1473-3099(24)00007-0"},{"key":"4269_CR19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X, Yin P, Zhu J, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394:1145\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(19)30427-1.","journal-title":"Lancet."},{"key":"4269_CR20","doi-asserted-by":"publisher","unstructured":"GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2204\u20132256. https:\/\/doi.org\/10.1016\/S0140-6736(24)00685-8.","DOI":"10.1016\/S0140-6736(24)00685-8"},{"key":"4269_CR21","doi-asserted-by":"publisher","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2162\u20132203.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4.","DOI":"10.1016\/S0140-6736(24)00933-4"},{"key":"4269_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s44197-023-00109-0","volume":"13","author":"G Cao","year":"2023","unstructured":"Cao G, Liu J, Liu M. Global, regional, and national trends in incidence and mortality of primary liver cancer and its underlying etiologies from 1990 to 2019: results from the Global Burden of Disease Study 2019. J Epidemiol Glob Health. 2023;13:344\u201360. https:\/\/doi.org\/10.1007\/s44197-023-00109-0.","journal-title":"J Epidemiol Glob Health."},{"key":"4269_CR23","doi-asserted-by":"publisher","first-page":"112023","DOI":"10.1016\/j.envres.2021.112023","volume":"204","author":"X Yang","year":"2022","unstructured":"Yang X, Zhang T, Zhang X, Chu C, Sang S. Global burden of lung cancer attributable to ambient fine particulate matter pollution in 204 countries and territories, 1990\u20132019. Environ Res. 2022;204. https:\/\/doi.org\/10.1016\/j.envres.2021.112023.","journal-title":"Environ Res."},{"key":"4269_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/23744235.2022.2092647","volume":"54","author":"Y Wang","year":"2022","unstructured":"Wang Y, Jing W, Liu J, Liu M. Global trends, regional differences and age distribution for the incidence of HIV and tuberculosis co-infection from 1990 to 2019: results from the Global Burden of Disease Study 2019. Infect Dis (Lond). 2022;54:773\u201383. https:\/\/doi.org\/10.1080\/23744235.2022.2092647.","journal-title":"Infect Dis (Lond)."},{"key":"4269_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","volume":"12","author":"N Salari","year":"2023","unstructured":"Salari N, Kanjoori AH, Hosseinian-Far A, Hasheminezhad R, Mansouri K, et al. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis. Infect Dis Poverty. 2023;12:57. https:\/\/doi.org\/10.1186\/s40249-023-01107-x.","journal-title":"Infect Dis Poverty."},{"key":"4269_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1473-3099(13)70030-6","volume":"13","author":"I Abubakar","year":"2013","unstructured":"Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis. 2013;13:529\u201339. https:\/\/doi.org\/10.1016\/S1473-3099(13)70030-6.","journal-title":"Lancet Infect Dis."},{"key":"4269_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","volume":"10","author":"K Dheda","year":"2024","unstructured":"Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, et al. Multidrug-resistant tuberculosis Nat Rev Dis Primers. 2024;10:22. https:\/\/doi.org\/10.1038\/s41572-024-00504-2.","journal-title":"Multidrug-resistant tuberculosis. Nat Rev Dis Primers."},{"key":"4269_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.5588\/ijtld.21.0664","volume":"26","author":"P Aia","year":"2022","unstructured":"Aia P, Viney K, Kal M, Kisomb J, Yasi R, et al. The economic burden of TB faced by patients and affected families in Papua New Guinea. Int J Tuberc Lung Dis. 2022;26:934\u201341. https:\/\/doi.org\/10.5588\/ijtld.21.0664.","journal-title":"Int J Tuberc Lung Dis."},{"key":"4269_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijid.2023.04.392","volume":"132","author":"G Diriba","year":"2023","unstructured":"Diriba G, Alemu A, Yenew B, Tola HH, Gamtesa DF, et al. Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2023;132:50\u201363. https:\/\/doi.org\/10.1016\/j.ijid.2023.04.392.","journal-title":"Int J Infect Dis."},{"key":"4269_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","volume":"24","author":"H Lv","year":"2024","unstructured":"Lv H, Zhang X, Zhang X, Bai J, You S, et al. Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019. BMC Infect Dis. 2024;24:243. https:\/\/doi.org\/10.1186\/s12879-024-09079-5.","journal-title":"BMC Infect Dis."},{"key":"4269_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/thoraxjnl-2015-207638","volume":"71","author":"Y Balabanova","year":"2016","unstructured":"Balabanova Y, Ignatyeva O, Fiebig L, Riekstina V, Danilovits M, et al. Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference? Thorax. 2016;71:854\u201361. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207638.","journal-title":"Thorax."},{"key":"4269_CR32","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2147\/IDR.S164596","volume":"11","author":"MG Wang","year":"2018","unstructured":"Wang MG, Huang WW, Wang Y, Zhang YX, Zhang MM, et al. Association between tobacco smoking and drug-resistant tuberculosis. Infect Drug Resist. 2018;11:873\u201387. https:\/\/doi.org\/10.2147\/IDR.S164596.","journal-title":"Infect Drug Resist."},{"key":"4269_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tube.2017.01.002","volume":"103","author":"F Di Gennaro","year":"2017","unstructured":"Di Gennaro F, Pizzol D, Cebola B, Stubbs B, Monno L, et al. Social determinants of therapy failure and multi drug resistance among people with tuberculosis: a review. Tuberculosis (Edinb). 2017;103:44\u201351. https:\/\/doi.org\/10.1016\/j.tube.2017.01.002.","journal-title":"Tuberculosis (Edinb)."},{"key":"4269_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jgar.2024.05.012","volume":"38","author":"D Singh","year":"2024","unstructured":"Singh D, Sarkar B, Yadav S, Sarkar K. Silent epidemic of silicotuberculosis in India and emergence of multidrug-resistant tuberculosis? J Glob Antimicrob Resist. 2024;38:163\u20136. https:\/\/doi.org\/10.1016\/j.jgar.2024.05.012.","journal-title":"J Glob Antimicrob Resist."},{"key":"4269_CR35","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1186\/s12889-021-12056-1","volume":"21","author":"J Nidoi","year":"2021","unstructured":"Nidoi J, Muttamba W, Walusimbi S, Imoko JF, Lochoro P, et al. Impact of socio-economic factors on tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study. BMC Public Health. 2021;21:2167. https:\/\/doi.org\/10.1186\/s12889-021-12056-1.","journal-title":"BMC Public Health."},{"key":"4269_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.rppnen.2017.11.003","volume":"24","author":"R Duarte","year":"2018","unstructured":"Duarte R, L\u00f6nnroth K, Carvalho C, Lima F, Carvalho ACC, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology. 2018;24:115\u20139. https:\/\/doi.org\/10.1016\/j.rppnen.2017.11.003.","journal-title":"Pulmonology."},{"key":"4269_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00281-018-0725-6","volume":"41","author":"D Hertz","year":"2019","unstructured":"Hertz D, Schneider B. Sex differences in tuberculosis. Semin Immunopathol. 2019;41:225\u201337. https:\/\/doi.org\/10.1007\/s00281-018-0725-6.","journal-title":"Semin Immunopathol."},{"key":"4269_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41586-024-07789-z","volume":"633","author":"T Lakshmikanth","year":"2024","unstructured":"Lakshmikanth T, Consiglio C, Sardh F, Forlin R, Wang J, et al. Immune system adaptation during gender-affirming testosterone treatment. Nature. 2024;633:155\u201364. https:\/\/doi.org\/10.1038\/s41586-024-07789-z.","journal-title":"Nature."},{"key":"4269_CR39","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.it.2022.06.004","volume":"43","author":"M Gupta","year":"2022","unstructured":"Gupta M, Srikrishna G, Klein SL, Bishai WR. Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. Trends Immunol. 2022;43:640\u201356. https:\/\/doi.org\/10.1016\/j.it.2022.06.004.","journal-title":"Trends Immunol."},{"key":"4269_CR40","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41564-024-01678-x","volume":"9","author":"LRL Davies","year":"2024","unstructured":"Davies LRL, Wang C, Steigler P, Bowman KA, Fischinger S, et al. Age and sex influence antibody profiles associated with tuberculosis progression. Nat Microbiol. 2024;9:1513\u201325. https:\/\/doi.org\/10.1038\/s41564-024-01678-x.","journal-title":"Nat Microbiol."},{"key":"4269_CR41","doi-asserted-by":"publisher","first-page":"1146704","DOI":"10.3389\/fimmu.2023.1146704","volume":"14","author":"A Grifoni","year":"2023","unstructured":"Grifoni A, Alonzi T, Alter G, Noonan DM, Landay AL, et al. Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis. Front Immunol. 2023;14:1146704. https:\/\/doi.org\/10.3389\/fimmu.2023.1146704.","journal-title":"Front Immunol."},{"key":"4269_CR42","doi-asserted-by":"publisher","unstructured":"Seaworth BJ, Griffith DE. Therapy of multidrug-resistant and extensively drug-resistant tuberculosis. Microbiol Spectr. 2017;5(2):https:\/\/doi.org\/10.1128\/microbiolspec.tnmi7-0042-2017.","DOI":"10.1128\/microbiolspec.tnmi7-0042-2017"},{"key":"4269_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/cid\/ciy883","volume":"69","author":"H Huang","year":"2019","unstructured":"Huang H, Ding N, Yang T, Li C, Jia X, et al. Cross-sectional whole-genome sequencing and epidemiological study of multidrug-resistant Mycobacterium tuberculosis in China. Clin Infect Dis. 2019;69:405\u201313. https:\/\/doi.org\/10.1093\/cid\/ciy883.","journal-title":"Clin Infect Dis."},{"key":"4269_CR44","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2471\/BLT.19.229997","volume":"97","author":"I Meshkov","year":"2019","unstructured":"Meshkov I, Petrenko T, Keiser O, Estill J, Revyakina O, et al. Variations in tuberculosis prevalence, Russian Federation: a multivariate approach. Bull World Health Organ. 2019;97:737-745A. https:\/\/doi.org\/10.2471\/BLT.19.229997.","journal-title":"Bull World Health Organ."},{"key":"4269_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.1994.03510330043032","volume":"271","author":"AB Bloch","year":"1994","unstructured":"Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA. 1994;271:665\u201371.","journal-title":"JAMA"},{"key":"4269_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12916-024-03532-7","volume":"22","author":"V Gunsaru","year":"2024","unstructured":"Gunsaru V, Henrion MYR, McQuaid CF. The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC Med. 2024;22:312. https:\/\/doi.org\/10.1186\/s12916-024-03532-7.","journal-title":"BMC Med."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04269-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04269-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04269-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:53:59Z","timestamp":1757310839000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04269-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4269"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04269-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5395271\/v1","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and informed consent were waived because the GBD 2021 study is publicly available and no identifiable information was included in the analyses.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}